$1,000,000 awarded for ALS research
Thank you to the distinguished scientists and research leaders on our
Scientific Advisory Board. Their work ensures that the contributions
we raise support the most promising ALS research.
Scientific Advisory Board. Their work ensures that the contributions
we raise support the most promising ALS research.
Yuna Ayala, MD
St. Louis University, School of Medicine
Yuna Ayala received her PhD from Washington University in St. Louis and continued as a postdoctoral fellow in Trieste, Italy in the lab of Dr. Tito Baralle at the ICGEB. She also worked with Dr. Tom Misteli at the NCI/NIH in Bethesda as part of her postdoctoral training. Yuna is Associate Professor and Vice Chair of the Doisy Department of Biochemistry and Molecular Biology at Saint Louis University School of Medicine. Her research team focuses on uncovering the role of RNA binding proteins in neurodegenerative disorders, in particular ALS and frontotemporal dementia. The group forms part of numerous collaborations with teams in the US and abroad to highlight basic molecular mechanisms involved in pathogenesis.
Sami Barmada, MD, PhD
Associate Professor, University of Michigan
Dr. Barmada received his M.D. and Ph.D. from Washington University in St. Louis in 2006, and completed his neurology residency at the University of California, San Francisco, in 2010. He moved to the University of Michigan as Assistant Professor of Neurology in 2013, and was promoted to Associate Professor with tenure in 2020.
In recognition of his original research on RNA and protein metabolism in ALS and FTD, Dr. Barmada was awarded the Young Physician Scientist Award from the American Society for Clinical Investigation in 2014, the distinguished Angela Dobson and Lyndon Welch Research Professorship in 2015, and the Derek Denny Brown Award for Basic Science Research from the American Neurological Society in 2022.
Dr. Barmada serves on the executive advisory board of the Robert Packard Center for ALS Research, and acts on the scientific advisory boards of the Live Like Lou Foundation, Synapticure, and Ninesquare Therapeutics. He has taken an active role in raising awareness of ALS and FTD in the community, participates in several local and national fundraising efforts, and helps guide priorities for national research funding through NIH-sponsored panels.
In recognition of his original research on RNA and protein metabolism in ALS and FTD, Dr. Barmada was awarded the Young Physician Scientist Award from the American Society for Clinical Investigation in 2014, the distinguished Angela Dobson and Lyndon Welch Research Professorship in 2015, and the Derek Denny Brown Award for Basic Science Research from the American Neurological Society in 2022.
Dr. Barmada serves on the executive advisory board of the Robert Packard Center for ALS Research, and acts on the scientific advisory boards of the Live Like Lou Foundation, Synapticure, and Ninesquare Therapeutics. He has taken an active role in raising awareness of ALS and FTD in the community, participates in several local and national fundraising efforts, and helps guide priorities for national research funding through NIH-sponsored panels.
Brian C. Callaghan, MD
Assistant Professor, University of Michigan Medical School
Associate Director of Research, University of Michigan Comprehensive ALS Clinic
Dr. Callaghan completed his medical degree and neurology residency at the University of Pennsylvania. He completed a fellowship in neuromuscular disease at the University of Michigan. He also has a Master’s degree in clinical research design and statistical analysis from the University of Michigan School of Public Health.
Dr. Callaghan is an Associate Professor of Neurology, the Fovette E. Dush early career professor of neurology, and a staff physician at the Ann Arbor Veterans Affairs Hospital. He has over 120 peer- reviewed publications including more than 40 first and last author publications. He has received grant funding from the NIH (NIDDK R-01 grant, NIH K23 grant), VA (CSR&D Merit grant), ADA (Junior Faculty Award), JDRF, and the AAN. He serves as the co-section editor for the Innovations in Care Delivery website for the Neurology journal.
Dr. Callaghan also serves as the vice chair of the AAN Health Services Research subcommittee. He is currently the vice chair of the Peripheral Nerve Society’s Education committee and a board member for the International Diabetes Neuropathy Consortium. He serves on the MDiabetes Enrichment committee. He recently became the co-Director of the Neuromuscular division and the Associate Program Director of research for the neurology residency program. He previously served as the diabetic neuropathy chair for the scientific sessions meeting planning committee of the ADA, as the co-chair for the health services research special interest group for the ANA, on the Michigan Program on Value Enhancement (MPrOVE) committee, and on the national Epic adult neurology steering board.
Dr. Callaghan has two main research interests, the epidemiology of peripheral neuropathy and neurology health services research.
Dr. Callaghan is an Associate Professor of Neurology, the Fovette E. Dush early career professor of neurology, and a staff physician at the Ann Arbor Veterans Affairs Hospital. He has over 120 peer- reviewed publications including more than 40 first and last author publications. He has received grant funding from the NIH (NIDDK R-01 grant, NIH K23 grant), VA (CSR&D Merit grant), ADA (Junior Faculty Award), JDRF, and the AAN. He serves as the co-section editor for the Innovations in Care Delivery website for the Neurology journal.
Dr. Callaghan also serves as the vice chair of the AAN Health Services Research subcommittee. He is currently the vice chair of the Peripheral Nerve Society’s Education committee and a board member for the International Diabetes Neuropathy Consortium. He serves on the MDiabetes Enrichment committee. He recently became the co-Director of the Neuromuscular division and the Associate Program Director of research for the neurology residency program. He previously served as the diabetic neuropathy chair for the scientific sessions meeting planning committee of the ADA, as the co-chair for the health services research special interest group for the ANA, on the Michigan Program on Value Enhancement (MPrOVE) committee, and on the national Epic adult neurology steering board.
Dr. Callaghan has two main research interests, the epidemiology of peripheral neuropathy and neurology health services research.
John K. Kim, PhD
Associate Professor, John Hopkins University
Dr. Kim completed his doctoral training in biochemistry and molecular biology at the Universityof California Davis. From 2001-2006 he completed a postdoctoral fellowship at Harvard Medical School and Massachusetts General Hospital. Since 2006 he has served on the faculty of the Life Sciences Institute and Department of Human Genetics at the University of Michigan and University of Michigan Medical School. From 2009-2013 he was a Pew Scholar in the field of Biomedical Sciences. He was an associate professor in the Department of Human Genetics at the University of Michigan Medical School, and a research associate professor in the Life Sciences Institute at the University of Michigan. He is an associate professor in the Biology Department at Johns Hopkins. His lab focuses on deciphering the biological function of microRNAs and other small RNAs expressed in the genome.
Aaron D. Gitler, PhD
Professor of Genetics, Stanford University
Aaron D. Gitler is Professor of Genetics at Stanford University. He received his B.S. degree from Penn State University and earned his Ph.D. at the University of Pennsylvania. Then he performed his postdoctoral training with Dr. Susan Lindquist at the Whitehead Institute for Biomedical Research and MIT. In 2007, he established his laboratory at the University of Pennsylvania. In 2012, he moved to Stanford University. His laboratory has been using a combination of yeast and human genetics approaches to investigate pathogenic mechanisms of human neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. He was a Pew Scholar in the Biomedical Sciences, a Rita Allen Scholar and a recipient of the NIH Director’s New Innovator Award, and the NIH NINDS Research Program Award. He is the recipient of the 2017 Merz Guest Professorship Award.
Mark Bromberg, MD
University of Utah
Dr. Mark Bromberg is a Professor of Neurology at the University of Utah. He received a doctoral degree in Neurophysiology from the University of Vermont and his medical degree and neurology residency training from the University of Michigan. He also completed a fellowship in clinical neurophysiology and neuromuscular diseases at the University of Michigan. He was on the faculty at the University of Michigan before moving to the University of Utah in 1994.
His clinical interests are in neuromuscular disorders and electrodiagnosis (EMG). Within neuromuscular disorders his focus is on amyotrophic lateral sclerosis (ALS), peripheral neuropathies, and myasthenia gravis. He co-directs the Motor Neuron Disease (ALS) clinic at the University of Utah, which certified by both the Muscular Dystrophy Association and ALS Association as a Clinic of Excellence.
His research interests on electrodiagnosis focus on advanced EMG techniques to improving diagnostic certainty for inflammatory neuropathies and ALS. He has organized and hosted two international symposia on motor unit number estimation (MUNE) and quantitative EMG (QEMG). He is active in research on issues related to quality of life for ALS patients and caregivers. He received the 2011 Distinguished Researcher Award from the American Association of Neuromuscular & Electrodiagnostic Medicine.
Dr. Bromberg has published over 130 articles and 30 book chapter, has edited or co-edited 4 books, and has written “Navigating Life with ALS” for the American Academy of Neurology and “Peripheral Neuropathies: A Practical Approach.” He is on the editorial board of Muscle & Nerve, Clinical Neurophysiology and Journal of Neuromuscular Diseases and serves as an ad hoc reviewer for other journals.
His clinical interests are in neuromuscular disorders and electrodiagnosis (EMG). Within neuromuscular disorders his focus is on amyotrophic lateral sclerosis (ALS), peripheral neuropathies, and myasthenia gravis. He co-directs the Motor Neuron Disease (ALS) clinic at the University of Utah, which certified by both the Muscular Dystrophy Association and ALS Association as a Clinic of Excellence.
His research interests on electrodiagnosis focus on advanced EMG techniques to improving diagnostic certainty for inflammatory neuropathies and ALS. He has organized and hosted two international symposia on motor unit number estimation (MUNE) and quantitative EMG (QEMG). He is active in research on issues related to quality of life for ALS patients and caregivers. He received the 2011 Distinguished Researcher Award from the American Association of Neuromuscular & Electrodiagnostic Medicine.
Dr. Bromberg has published over 130 articles and 30 book chapter, has edited or co-edited 4 books, and has written “Navigating Life with ALS” for the American Academy of Neurology and “Peripheral Neuropathies: A Practical Approach.” He is on the editorial board of Muscle & Nerve, Clinical Neurophysiology and Journal of Neuromuscular Diseases and serves as an ad hoc reviewer for other journals.
|
"The funds provided by Active Against ALS significantly aided in a
collaborative project looking at how stress impacts production of these toxic proteins. This work would not have been done without the support of Active Against ALS and our results will soon be published. They suggest that targeting the stress pathways directly are unlikely tofix the underlying problems - meaning that we need to target our therapeutic strategies at an earlier stage in the pathogenic cascade." - Dr. Peter Todd Ann Arbor VA Medical Center & University of Michigan |
Active Against ALS
2232 S. Main Street #323 Ann Arbor, MI 48103 |
|